Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07219134 · ClinicalTrials.gov registry record
Pilot Investigation of Dual Energy CT Imaging on an Online Adaptive Radiation Therapy System
A clinical trial of Genitourinary System Carcinoma and Malignant Pelvic Neoplasm, sponsored by University of Michigan Rogel Cancer Center.
- Recruiting
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT07219134: Recruiting study of Genitourinary System Carcinoma and Malignant Pelvic Neoplasm, sponsored by University of Michigan Rogel Cancer Center.
NCT07219134 is a study of Genitourinary System Carcinoma and Malignant Pelvic Neoplasm that is actively recruiting participants, run by University of Michigan Rogel Cancer Center. The registered enrollment target is 30 participants, below the 2,399-participant average among 3 other Genitourinary System Carcinoma trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07219134, a study of Genitourinary System Carcinoma and Malignant Pelvic Neoplasm, is actively recruiting participants, sponsored by University of Michigan Rogel Cancer Center.
- RECRUITING
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being done to see if researchers can find a better way to image a patient's tumor during radiation treatment.
Primary Outcome
The primary analysis will compare imaging quality endpoints processed by DE-CBCT and the standard of care SE-CBCT, with the latter representing the standard clinical acquisition. Descriptive statistics will be computed for the image quality metrics from each imaging modality and for the difference in metrics between the modalities. A paired t-test or Wilcoxon signed-rank test will compare the distribution of the image quality metrics between DE-CBCT and standard of care SE-CBCT. Secondary analys
Conditions Studied
Interventions
- OTHER Non-Interventional Study
Study Locations (1)
Michigan
- University of Michigan Comprehensive Cancer Center - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-06-06 |
| Est. Completion | 2027-06 |
What NCT07219134 shows while recruiting
NCT07219134 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 2,399-participant average among 3 other Genitourinary System Carcinoma trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Genitourinary System Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which Non-Interventional Study is the first listed.
NCT07219134 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT07219134 about?
NCT07219134 is a clinical study titled "Pilot Investigation of Dual Energy CT Imaging on an Online Adaptive Radiation Therapy System". This study is being done to see if researchers can find a better way to image a patient's tumor during radiation treatment.
What is the current status of trial NCT07219134?
This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2025-06-06. Estimated completion is 2027-06.
What conditions does trial NCT07219134 study?
This clinical trial studies the following conditions: Genitourinary System Carcinoma, Malignant Pelvic Neoplasm.
What interventions are being tested in trial NCT07219134?
The interventions under investigation include: Non-Interventional Study (OTHER).
Who is sponsoring clinical trial NCT07219134?
This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07219134 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Genitourinary System Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Cancer Genetic Testing in Ethnic Populations
RECRUITING · NA
-
Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
RECRUITING
-
Home Base Telemonitoring in Gastrointestinal, Genitourinary, or Gynecologic Cancer Patients Undergoing Abdominal Surgery
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI